Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MEI Pharma (GB:0JW9)
LSE:0JW9
MEI Pharma (0JW9) Share Price & Analysis
0 Followers
0JW9 Stock Chart & Stats
Day’s Range$3.05 - $3.05
52-Week Range― - ―
Previous Close$3.05
Volume88.00
Average Volume (3M)N/A
Market Cap
$20.39M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 09, 2024EPS Estimate
-$1.49Last Dividend Ex-Date
Nov 16, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$7.00Price Target Upside129.51% Upside
Rating ConsensusHold
Number of Analyst Covering1
MEI Pharma News
PremiumCompany Announcements
MEI Pharma Announces Flexible $25 Million Funding Strategy
0JW9 FAQ
What was MEI Pharma’s price range in the past 12 months?
Currently, no data Available
What is MEI Pharma’s market cap?
Currently, no data Available
When is MEI Pharma’s upcoming earnings report date?
MEI Pharma’s upcoming earnings report date is May 09, 2024 which is in 6 days.
How were MEI Pharma’s earnings last quarter?
MEI Pharma released its earnings results on Feb 13, 2024. The company reported -$1.66 earnings per share for the quarter, missing the consensus estimate of -$1.413 by -$0.247.
Is MEI Pharma overvalued?
According to Wall Street analysts MEI Pharma’s price is currently Undervalued.
Does MEI Pharma pay dividends?
MEI Pharma pays a Notavailable dividend of $1.75 which represents an annual dividend yield of N/A. See more information on MEI Pharma dividends here
What is MEI Pharma’s EPS estimate?
MEI Pharma’s EPS estimate is -$1.49.
How many shares outstanding does MEI Pharma have?
Currently, no data Available
What happened to MEI Pharma’s price movement after its last earnings report?
MEI Pharma reported an EPS of -$1.66 in its last earnings report, missing expectations of -$1.413. Following the earnings report the stock price went down -4.442%.
Which hedge fund is a major shareholder of MEI Pharma?
Among the largest hedge funds holding MEI Pharma’s share is Carlson Capital LP. It holds MEI Pharma’s shares valued at 429K.
---
MEI Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.33%
12-Months-Change
Fundamentals
Return on Equity
36.80%
Trailing 12-Months
Asset Growth
-46.79%
Trailing 12-Months
Company Description
MEI Pharma
MEI Pharma, Inc. engages in the clinical development of therapies for cancer. Its drug candidates includes Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid leukemia and myelodysplastic syndrome. Its pipeline also consists of ME-401, an oral PI3K delta inhibitor; Voruciclib, an oral CDK inhibitor; and ME-344, a mitochondrial inhibitor. The company was founded on December 1, 2000 and is headquartered in San Diego, CA.
---
0JW9 Earnings Call
Q4 2023
0:00 / 0:00
---
0JW9 Stock 12 Months Forecast
Average Price Target
$7.00
▲(129.51% Upside)
Technical Analysis
Best Analysts Covering 0JW9
1 Year
1 Year Success Rate
13/33 ratings generated profit
1 Year Average Return
-10.86%
reiterated a buy rating 12 months ago
Copying Leah R. Cann's trades and holding each position for 1 Year would result in 39.39% of your transactions generating a profit, with an average return of -10.86% per trade.
---